Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS

NCT06006949 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Roxadustat
DRUG: Luspatercept

Sponsor

Peking Union Medical College Hospital